SPONSOR
Peking University Third Hospital
Total Trials
2
Recruiting
2
Phases
N/A
Peking University Third Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Refractory Systemic Lupus Erythematosus, Anterior Cruciate Ligament Injuries.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peking University Third Hospital
How many clinical trials has Peking University Third Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Peking University Third Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Refractory Systemic Lupus Erythematosus, Anterior Cruciate Ligament Injuries. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peking University Third Hospital research focus on?
Peking University Third Hospital clinical trials span Refractory Systemic Lupus Erythematosus, Anterior Cruciate Ligament Injuries. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Peking University Third Hospital clinical trial?
To participate in a Peking University Third Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking University Third Hospital trials with current recruitment status updated daily.
Clinical Trials by Peking University Third Hospital
NCT06513429
Recruiting
IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)
Refractory Systemic Lupus Erythematosus
NCT07306221
Recruiting
Effect of Visual-Guided Balance Training on Knee Motor Function and Biomechanical Characteristics After ACL Reconstruction
Anterior Cruciate Ligament Injuries
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology